Filtering out the noise and focusing on what is most important and impactful is complicated, and if not done thoughtfully, can inform misguided business decisions. Our insights simplify the complex and drive focus on the most relevant strategic and operational factors.
Voice-activated systems are becoming more prevalent.
Digital therapeutics (DTx) are expanding into new domains like oncology, women's health and pediatrics.
Patients are demanding more portals and digital engagement.
Advanced analytics are enabling proactive and targeted population health management strategies.
Telehealth growth is more targeted and specialized.
Clinicians' trust in AI is revolutionizing diagnosis and treatment planning.
Consumer-facing digital technologies continue to rise.
Finding a balance between drug affordability, access, and innovation remains a critical challenge.
Healthcare transparency will continue to be a priority for federal policymakers.
Risk arrangements in the commercial market are accelerating.
Employers are directly contracting with healthcare providers to manage rising healthcare costs.
AI will continue expanding across the healthcare continuum, with momentum building in the front office.
